SIBA

Synonyms: 5'-Isobutylthioadenosine; 5'-Deoxy-5'-isobutylthioadenosine
SIBA (5'-Isobutylthioadenosine) 是一种 Transmethylation 抑制剂(SAH (MS-U46600) 类似物),具有强大的抗增殖活性,通过阻断甲基化尤其是病毒 mRNA 的 5' 端加帽,可逆地抑制 HSV-1 的产生,同时还能抑制肿瘤细胞系的体外生长和体内转移扩散,可用于癌症、HSV-1 感染和抗疟疾的研究。
产品编号: MS-N27422 纯度: 99.64% CAS No.: 35899-54-8 分子式: C14H21N5O3S 分子量: 339.41
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
10mM * 1mL in DMSO
询价
3-5 天
1mg
询价
3-5 天
5mg
询价
3-5 天
10mg
询价
3-5 天
25mg
询价
3-5 天
50mg
询价
3-5 天
100mg
询价
3-5 天
200mg
询价
询价
500mg
询价
询价

产品描述

SIBA (5'-Isobutylthioadenosine) 是一种 Transmethylation 抑制剂(SAH (MS-U46600) 类似物),具有强大的抗增殖活性,通过阻断甲基化尤其是病毒 mRNA 的 5' 端加帽,可逆地抑制 HSV-1 的产生,同时还能抑制肿瘤细胞系的体外生长和体内转移扩散,可用于癌症、HSV-1 感染和抗疟疾的研究。

生物实验数据

生物活性 SIBA (5'-Isobutylthioadenosine) is a transmethylation inhibitor (an analog of SAH (MS-U46600)) with potent antiproliferative activity that reversibly inhibits HSV-1 production by blocking methylation, particularly 5' capping of viral mRNA, and also inhibits the in vitro growth and in vivo metastatic spread of tumor cell lines, making it useful for research on cancer, HSV-1 infection, and antimalaria.
IC50 & Target

Plasmodium

 

HSV-1

 

体外研究
(In Vitro)

SIBA (0.5 mM; 24-96 h) shows strong anti-proliferative activity against 3LL and RMS-J1 tumour cells.
SIBA (1 mM; 12, 24 h) reversibly inhibits HSV production in HEp2 cells (infected by HSV-1).
SIBA inhibits protein synthesis by 98% after 10 h infection of HEp2 cells (infected by HSV-1).
SIBA (1 mM; 8.5 h) inhibits protein synthesis and RNA methylation in HEp2 cells (infected by HSV-1).
SIBA (0.5, 1.0 mM; 24, 48 h) inhibits the conversion of putrescine into spermidine and/or spermine and that this inhibition is a reversible one (interferes with polyamine biosynthesis, probably by blocking aminopropyltransferase).

Cell Proliferation Assay

Cell Line: 3 LL and RMS-J1 cells
Concentration: 0.5 mM
Incubation Time: 24-96 h
Result: Inhibited 3LL and RMS-J1 tumor cell growth potently by 96% and 88%, respectively.

Cell Viability Assay

Cell Line: HEp2 cells (infected by HSV-1)
Concentration: 1 mM
Incubation Time: 12, 24 h
Result: Decreased virus production by 88.4 and 98.2% when at 12 and 24 h, respectively.

Cell Viability Assay

Cell Line: HEp2 cells (infected by HSV-1)
Concentration: 1 mM
Incubation Time: 8.5 h
Result: Reduced protein synthesis by 41.3% in normal medium and by 63.5% in medium poor in methionine.
Inhibited RNA methylation by 65.4%.

Cell Viability Assay

Cell Line: chick embryo fibroblasts
Concentration: 0.5, 1.0 mM
Incubation Time: 24, 48 h
Result: Inhibited the uptake of the radioactive diamine and that the inhibition was dose-dependent.
Markedly inhibited the formation of [14C]spermidine and [14C]spermine from [14C]putrescine.
Inhibited the growth of chick embryo fibroblasts mainly after exposure for 48 h.
体内研究
(In Vivo)

SIBA (150 mg/kg; i.p.; twice weekly for 3 weeks) inhibits tumor growth in vivo.
SIBA (15 mg/kg; i.p.; thrice weekly for 4 weeks) inhibits metastatic spread of RMS-J1 cells in vivo.

Animal Model: C57BL/6 female mice (4-8 weeks old).
Dosage: 150 mg/kg
Administration: Intraperitoneal injection; twice weekly for 3 weeks.
Result: Significantly reduced the median number of lung metastases.
Animal Model: Adult syngeneic Wistar AG rats (8-week-old; subcutaneously grafted with RMS-J1 cells).
Dosage: 15 mg/kg
Administration: Intraperitoneal injection; thrice weekly for 4 weeks.
Result: Inhibited in vivo metastatic spread of RMS-J1 cells, and showed median numbers of lung metastatic nodules was 26.
性状 固体
颜色 Off-white to gray

化学信息

分子量 339.41
分子式 C14H21N5O3S
CAS No. 35899-54-8
别名 5'-Isobutylthioadenosine; 5'-Deoxy-5'-isobutylthioadenosine

储存&溶解度

体内实验配方
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (9.72 mM), Sonication is recommended.
请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。
储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 2 years
-20°C 1 year
运输条件 Room temperature in continental US; may vary elsewhere.
溶液配制表

DMSO 中的溶解度 : ≥ 100 mg/mL (294.63 mM; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

* "≥" means soluble, but saturation unknown.

可选溶剂浓度1 mg5 mg10 mg25 mg
DMSO1 mM2.9463 mL14.7314 mL29.4629 mL73.6572 mL
5 mM0.5893 mL2.9463 mL5.8926 mL14.7314 mL
10 mM0.2946 mL1.4731 mL2.9463 mL7.3657 mL
15 mM0.1964 mL0.9821 mL1.9642 mL4.9105 mL
20 mM0.1473 mL0.7366 mL1.4731 mL3.6829 mL
25 mM0.1179 mL0.5893 mL1.1785 mL2.9463 mL
30 mM0.0982 mL0.4910 mL0.9821 mL2.4552 mL
40 mM0.0737 mL0.3683 mL0.7366 mL1.8414 mL
50 mM0.0589 mL0.2946 mL0.5893 mL1.4731 mL
60 mM0.0491 mL0.2455 mL0.4910 mL1.2276 mL
80 mM0.0368 mL0.1841 mL0.3683 mL0.9207 mL
100 mM0.0295 mL0.1473 mL0.2946 mL0.7366 mL

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C, 2 years; -20°C, 1 year。-80°C储存时,请在2年内使用, -20°C储存时,请在1年内使用。

该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础